Highly active cysteine protease
Cathepsin K, a member of the papain family of cysteine proteases, acts upon proteins such as collagen, AL amyloid, kinin, and elastin. It is a lysosomal protease expressed primarily in osteoclasts, but also in other cell types such as macrophages. It functions in bone remodeling and is implicated in disease states such as osteoporosis, atherosclerosis, arthritis, and pycnodysostosis.
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account


Product Details
Alternative Name |
Cathepsin O, Cathepsin O2 |
---|---|
Formulation |
Liquid. In 50mM sodium acetate, pH 5.5, containing 50mM sodium chloride, 0.5mM EDTA and 5mM DTT. |
MW |
~26kDa |
Purity |
≥95% (SDS-PAGE) |
Source |
Produced in insect cells. Purified as full-length proenzyme (see Prod. No. BML-SE367), then auto-activated at low pH. Produced in a baculovirus expression system. |
Specific Activity |
≥1.5 U/mg. One unit hydrolyzes 1µmol Z-Phe-Arg-AMC substrate (OMNICATHEPSIN® Fluorogenic Substrate, Prod. No. BML-P139) per min. at 37°C. |
UniProt ID |
P43235 |
Handling & Storage
Use/Stability |
Stable for at least 6 months after receipt when stored at -80°C. |
---|---|
Handling |
Keep on dry ice. Avoid freeze/thaw cycles. After opening, prepare aliquots and store at -80°C. |
Long Term Storage |
-80°C |
Shipping |
Dry Ice |
Regulatory Status |
RUO – Research Use Only |
---|
- Mechanical strain modulates extracellular matrix degradation and byproducts in an isoform-specific manner: A. Yeganegi, et al.; Biochim. Biophys. Acta Gen. Subj. 1867, 130286 (2023), Abstract
- Potential benefit of the cathepsin S inhibitor, ASP1617, as a treatment for systemic lupus erythematosus: Y. Kawato, et al.; Eur. J. Pharmacol. 919, 174826 (2022), Abstract
- Two Tags in One Probe: Combining Fluorescence- and Biotin-based Detection of the Trypanosomal Cysteine Protease Rhodesain: C. Lemke, et al.; Chemistry 28, e202201636 (2022), Abstract
- A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells: D.M. Mellott, et al.; ACS Chem. Biol. 16, 642 (2021), Abstract — Full Text
- Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V: K. Bollavaram, et al.; Protein Sci. 30, 1131 (2021), Abstract
- Cathepsin K is a potent disaggregase of α-synuclein fibrils: McGlinchey, R. P., Lacy, S. M., et al.; Biochem. Biophys. Res. Commun. 529, 1106 (2020), Abstract
- Cell penetrable, clickable and tagless activity-based probe of human cathepsin L: D. Dana, et al.; Bioorg. Chem. 85, 505 (2019), Application(s): Activity assay, Abstract
- A type VII collagen subdomain mutant is thermolabile and shows enhanced proteolytic degradability – Implications for the pathogenesis of recessive dystrophic epidermolysis bullosa?: C. Windler, et al.; Biochim. Biophys. Acta Mol. Basis Dis. 1863, 52 (2017), Abstract
- Unexpected Activity of a Novel Kunitz-type Inhibitor: INHIBITION OF CYSTEINE PROTEASES BUT NOT SERINE PROTEASES: D. Smith, et al.; J. Biol. Chem. 291, 19220 (2016), Abstract — Full Text
- Matrix-metalloproteinase-9 is cleaved and activated by cathepsin K: J. Christensen, et al.; BMC Res. Notes 8, 322 (2015), Abstract — Full Text
- Over-expression of cystatin C in synovium does not reduce synovitis or cartilage degradation in established osteoarthritis: S. Kyostio-Moore, et al.; Arthritis. Res. Ther. 17, 5 (2015), Application(s): Western Blotting, Abstract — Full Text
- Development of a highly potent, selective, and cell-active Inhibitor of cysteine cathepsin L-A hybrid design approach: D. Dana, et al.; Chem. Commun. (Camb.) 50, 10875 (2014), Abstract
- Cathepsin S Cannibalism of Cathepsin K as a Mechanism to Reduce Type I Collagen Degradation: Z.T. Barry, et al.; J. Biol. Chem. 287, 27723 (2012), Application(s): Fluorescent Assay , Abstract — Full Text
- Manipulating substrate and pH in zymogr aphy protocols selectively distinguishes cathepsins K, L, S, and V activity in cells and tissues: C.L. Wilder, et al.; Arch. Biochem. Biophys. 516, 52 (2011), Application(s): Western Blot, Abstract — Full Text
Related Products

Alternative Name | Procathepsin O, Procathepsin O2, Procathepsin X |
---|---|
Purity | ≥95% (SDS-PAGE) |
Source | Produced in E. coli (aa 19-329). Methionine was introduced at aa 18 to create a new N-terminal sequence (MEEIL). |

Application | Activity assay, Fluorescent detection, HTS |
---|

Alternative Name | Boc-L-norleucinal |
---|---|
CAS | 104062-70-6 |
Couple Type | Inhibitor |
Purity | ≥98% (TLC) |
Datasheet, Manuals, SDS & CofA
Manuals And Inserts
Certificate of Analysis
Please enter the lot number as featured on the product label
SDS
Enzo Life Science provides GHS Compliant SDS
If your language is not available please fill out the SDS request form